GE HealthCare Technologies (NASDAQ:GEHC) CEO Peter Arduini Purchases 4,169 Shares of Stock

GE HealthCare Technologies Inc. (NASDAQ:GEHC) CEO Peter Arduini purchased 4,169 shares of the firm’s stock in a transaction that occurred on Thursday, April 30th. The shares were bought at an average cost of $59.92 per share, with a total value of $249,806.48. Following the completion of the acquisition, the chief executive officer owned 259,424 shares of the company’s stock, valued at approximately $15,544,686.08. This trade represents a 1.63% increase in their ownership of the stock. The acquisition was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website.

GE HealthCare Technologies Price Performance

Shares of NASDAQ GEHC opened at $60.84 on Friday. The company has a debt-to-equity ratio of 0.95, a current ratio of 1.22 and a quick ratio of 1.13. The stock has a fifty day moving average price of $73.28 and a 200 day moving average price of $77.52. GE HealthCare Technologies Inc. has a 1-year low of $58.75 and a 1-year high of $89.77. The company has a market cap of $27.76 billion, a PE ratio of 14.56, a P/E/G ratio of 1.34 and a beta of 1.17.

GE HealthCare Technologies (NASDAQ:GEHC) last released its earnings results on Wednesday, April 29th. The company reported $0.99 EPS for the quarter, missing analysts’ consensus estimates of $1.07 by ($0.08). GE HealthCare Technologies had a net margin of 9.10% and a return on equity of 20.46%. The business had revenue of $5.13 billion during the quarter, compared to analyst estimates of $5.04 billion. During the same period last year, the business posted $1.01 EPS. GE HealthCare Technologies’s revenue was up 7.4% compared to the same quarter last year. GE HealthCare Technologies has set its FY 2026 guidance at 4.800-5.000 EPS. Sell-side analysts forecast that GE HealthCare Technologies Inc. will post 4.9 EPS for the current year.

GE HealthCare Technologies Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Friday, May 15th. Shareholders of record on Friday, April 3rd will be issued a $0.035 dividend. The ex-dividend date of this dividend is Thursday, April 2nd. This represents a $0.14 dividend on an annualized basis and a yield of 0.2%. GE HealthCare Technologies’s dividend payout ratio (DPR) is 3.35%.

Wall Street Analyst Weigh In

A number of equities research analysts have commented on GEHC shares. JPMorgan Chase & Co. reduced their target price on GE HealthCare Technologies from $80.00 to $65.00 and set a “neutral” rating for the company in a report on Thursday. Bank of America raised their target price on GE HealthCare Technologies from $82.00 to $92.00 and gave the company a “neutral” rating in a report on Monday, January 5th. Wall Street Zen downgraded GE HealthCare Technologies from a “buy” rating to a “hold” rating in a report on Saturday, March 21st. Mizuho reduced their target price on GE HealthCare Technologies from $95.00 to $90.00 and set an “outperform” rating for the company in a report on Monday, April 13th. Finally, The Goldman Sachs Group downgraded GE HealthCare Technologies from a “buy” rating to a “neutral” rating and reduced their target price for the company from $81.00 to $65.00 in a report on Thursday. Eight equities research analysts have rated the stock with a Buy rating, eight have issued a Hold rating and one has issued a Sell rating to the stock. Based on data from MarketBeat.com, the company presently has an average rating of “Hold” and an average target price of $80.67.

Institutional Inflows and Outflows

A number of hedge funds have recently made changes to their positions in GEHC. E Fund Management Hong Kong Co. Ltd. increased its position in shares of GE HealthCare Technologies by 130.7% in the third quarter. E Fund Management Hong Kong Co. Ltd. now owns 346 shares of the company’s stock valued at $26,000 after buying an additional 196 shares in the last quarter. Godsey & Gibb Inc. purchased a new position in shares of GE HealthCare Technologies in the third quarter valued at $26,000. Laurel Wealth Advisors LLC purchased a new position in shares of GE HealthCare Technologies in the fourth quarter valued at $26,000. Optima Capital LLC purchased a new position in shares of GE HealthCare Technologies in the fourth quarter valued at $27,000. Finally, Godfrey Financial Associates Inc. purchased a new stake in GE HealthCare Technologies during the 4th quarter worth about $27,000. Hedge funds and other institutional investors own 82.06% of the company’s stock.

More GE HealthCare Technologies News

Here are the key news stories impacting GE HealthCare Technologies this week:

• Positive Sentiment: Insiders bought shares: CEO Peter Arduini purchased 4,169 shares (~$59.92 avg; SEC filing), and director Frank R. Jimenez bought 1,750 shares (~$60.45 avg). Insider purchases are viewed as management expressing confidence in the company’s outlook. Arduini Form 4 Jimenez Form 4
• Neutral Sentiment: Q1 results were mixed: revenue beat estimates ($5.13B vs ~$5.03B) but EPS missed ($0.99 vs $1.07 consensus); revenue rose Y/Y but margins compressed. The topline strength helps the growth story, while margin pressure explains near‑term caution. Q1 Press Release
• Neutral Sentiment: Operational updates: GEHC is combining Imaging and Advanced Visualization Solutions into Advanced Imaging Solutions and announced executive changes intended to improve execution — a strategic move but one that may take time to show benefit. Operational Updates
• Negative Sentiment: Guidance cut and margin pressure: Management trimmed FY26 EPS guidance to $4.80–5.00 (below consensus ~5.05) and cited inflation, higher chip/oil/freight costs and supply pressures — the primary driver of the recent sell‑off. Reuters: Guidance Cut
• Negative Sentiment: Analyst downgrades/price‑target cuts: JPMorgan and Citigroup cut targets from $80 to $65 and set neutral ratings, contributing to downward pressure; several other firms trimmed targets or adjusted ratings. These moves signal lowered near‑term expectations from buyside/sellside. Benzinga coverage
• Negative Sentiment: Investor litigation inquiry: Law firm Johnson Fistel is investigating potential claims against GEHC executives, adding legal/regulatory risk and potential headline volatility. GlobeNewswire: Litigation Notice

About GE HealthCare Technologies

GE HealthCare Technologies (NASDAQ: GEHC) is a global medical technology and diagnostics company that develops, manufactures and markets a broad range of products and services for healthcare providers. Its portfolio centers on diagnostic imaging systems, including MRI, CT, PET and X-ray modalities, as well as ultrasound equipment. The company also supplies patient monitoring and anesthesia delivery systems, interventional and surgical imaging solutions, and molecular imaging technologies used in both clinical care and research settings.

In addition to hardware, GE HealthCare offers software, analytics and lifecycle services aimed at improving clinical workflows and equipment uptime.